Medical cold compress eye patch as well as preparation method and application thereof

Through medical cold compress eye patches without drug active ingredients, using the combination of components such as carbomer and polyvinyl alcohol, the problems of insufficient breathability and viscosity of traditional cold compress methods are solved, and effective moisturizing and cooling of the eyes are achieved and relieved. Symptoms of dry eye disease.

CN119019795APending Publication Date: 2024-11-26HUBEI SHUBANG PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310595141.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-24
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Traditional cold compresses have poor breathability and insufficient viscosity, which can easily lead to skin irritation and allergies, and cannot effectively alleviate dry eye diseases.

Method used

Using medical cold compress eye patches without drug active ingredients, a combination of carbomer, polyvinyl alcohol, preservatives, pH adjusters and moisturizers can form an efficient gel liquid, providing good moisturizing and cooling effect, and through The reasonable ratio of carrier to gel solution creates a humid and closed environment and relieves eye fatigue and dry eye diseases.

Benefits of technology

It achieves a safe and non-irritating fit, significantly alleviates eye fatigue and dry eye diseases, provides good moisturizing and cooling effects, and improves the comfort of use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019795A_ABST
    Figure CN119019795A_ABST
Patent Text Reader

Abstract

The invention discloses a medical cold compress eye patch, the medical cold compress eye patch comprises a carrier and a gel solution attached to the carrier, the gel solution comprises carbomer, a preservative, polyvinyl alcohol, a pH value regulator, a humectant and purified water, and the mass ratio of the carbomer to the polyvinyl alcohol is (0.015-0.2): 1; the invention further discloses a preparation method and application of the medical cold compress eye patch. The problems that in the prior art, product components are too complex, and excessive medicinal components and essence are contained are well solved, and the product which does not contain active components, can assist in treating xerophthalmia, is not prone to falling off, is convenient to use and is mild and non-irritating to skin is developed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of medical devices, and in particular relates to a medical cold compress eye patch, a preparation method and use thereof for relieving dry eye syndrome. Background Art

[0002] Eyes are important organs of the human body, and eye protection is very important. With the increasing use of computers and mobile phones, people are using them for longer and longer periods of time. However, long-term use of mobile phones and computers, or long-term use of eyes, can lead to eye fatigue such as dry eyes and sore eyes. Many eye problems can be solved by cold compresses: for example, cold compresses can relieve eye pain and reduce symptoms of eye fatigue; cold compresses can be used to relieve frequent swollen eyelids; cold compresses for subconjunctival hemorrhage can shrink capillaries and reduce bleeding; they can clear the brain and eliminate eye bags and dark circles; in addition, if eye diseases can be treated with cold compresses in a timely manner, they will have a good alleviating effect.

[0003] The traditional cold compress method is to use a wet towel or ice bag to cool the eye skin. This method has the following problems: 1. Poor air permeability, which can easily make the user feel stuffy during cold compress and is less comfortable; 2. The viscosity is too low and it cannot stick to the skin naturally, so it is easy to fall off and inconvenient to use; 3. The eye skin is fragile and prone to infection, so it is more complicated to use when using a wet towel or ice bag for cold compress.

[0004] The cold compress patch is based on the traditional cold compress method. It is a new drug release system TDDS prepared based on polymer gel. It can achieve the effect of local cooling by taking away heat through the evaporation of water contained in the polymer gel. The common cold compress patches on the market contain medicinal ingredients or flavors, which are attached to non-woven fabrics through gel. The drugs are in direct contact with the skin, which can easily cause irritation or allergies, or have problems such as poor moisturizing effect, easy volatility, and insufficient viscosity. Summary of the invention

[0005] In order to solve the deficiencies of the prior art, especially the problem that eye patches with too many ingredients are prone to allergies, the present invention provides a medical cold compress eye patch without active pharmaceutical ingredients. The eye patch gel comprises carbomer, polyvinyl alcohol, a preservative, a pH adjuster and a moisturizer, which is safe and non-irritating. Through the coordinated use of the components, it not only has a good moisturizing and cooling effect, but also can assist in relieving dry eye syndrome.

[0006] The first aspect of the present invention provides a medical cold compress eye patch, which comprises a carrier and a gel liquid attached to the carrier, wherein the gel liquid includes carbomer, a preservative, polyvinyl alcohol, a pH adjuster, a moisturizer and purified water, and the mass ratio of the carbomer to the polyvinyl alcohol is in the range of 0.015 to 0.2:1.

[0007] The present invention achieves the effect of relieving dry eyes by rationally mixing carbomer and polyvinyl alcohol, and the carrier of the infiltrated gel solution creates a moist closed environment for the eye skin, maintains the stability of the tear film, thereby relieving discomfort symptoms such as eye fatigue, dryness, and foreign body sensation. More preferably, the mass ratio of the carbomer to the polyvinyl alcohol is in the range of 0.02 to 0.1:1.

[0008] According to one embodiment of the present invention, the preservative is selected from ethyl p-hydroxybenzoate; the pH adjuster is selected from triethanolamine; the moisturizer is selected from one or more of propylene glycol, 1,3-butylene glycol and glycerol; the mass percentages of each component are as follows: carbomer 0.01% to 1%, triethanolamine 0.01% to 0.50%, polyvinyl alcohol 0.1% to 1%, ethyl p-hydroxybenzoate 0.01% to 0.50%, moisturizer 6% to 30%, purified water 67.00% to 93.87%.

[0009] According to one embodiment of the present invention, the gel solution does not contain active pharmaceutical ingredients.

[0010] According to one embodiment of the present invention, the mass percentage of the carbomer is 0.02-0.5%; the mass percentage of the polyvinyl alcohol is 0.2-0.8%.

[0011] According to one embodiment of the present invention, the moisturizing agent is propylene glycol, 1,3-butylene glycol and glycerol; the mass percentage of the propylene glycol is 2-10%, the mass percentage of the 1,3-butylene glycol is 2-10%, and the mass percentage of the glycerol is 2-10%.

[0012] According to one embodiment of the present invention, the gel solution includes the following components in percentage by mass: carbomer 0.02% to 0.5%, triethanolamine 0.01% to 0.10%, polyvinyl alcohol 0.2% to 0.8%, ethyl p-hydroxybenzoate 0.01% to 0.20%, propylene glycol 2 to 10%, 1,3-butylene glycol 2 to 10%, glycerol 2 to 10%, and purified water 68.40% to 93.76%.

[0013] According to one embodiment of the present invention, the pH value of the gel solution is 4.5-7.5.

[0014] According to one embodiment of the present invention, the mass ratio of the carrier to the gel liquid is 1:3 to 1:5. It has been verified through experiments that the mass ratio of the carrier to the gel liquid is less than 1:3, that is, if the gel liquid is too little, the cold compress eye patch will be dry, not moisturizing enough, and cannot be well applied to the skin, and the cold compress time will also be shortened; if the gel liquid is too much, exceeding 1:5, after the carrier absorbs the gel liquid, it will bring a series of problems, for example, if there is too much liquid during use, it will be easier to spill and pour, which is not conducive to cleaning; if there is too much gel liquid, the packaging capacity design is limited, and if the seal is stuck with liquid, it will cause the seal to fail; too much gel liquid will also increase corporate costs and other problems.

[0015] According to one embodiment of the present invention, the carrier is a bamboo fiber non-woven fabric.

[0016] According to one embodiment of the present invention, the carbomer is carbomer 380. Carbomer 380, in combination with polyvinyl alcohol and a moisturizer, can stably infiltrate the carrier, has a good lamination effect, and forms a stable closed environment.

[0017] According to another aspect of the present invention, a method for preparing a medical cold compress eye patch is provided, comprising the following steps: preparing a gel solution according to a formula, placing a carrier into a packaging bag, taking the gel solution and adding it into the packaging bag so that the gel solution infiltrates the carrier; and preparing the medical cold compress eye patch.

[0018] According to one embodiment of the present invention, the following steps are included:

[0019] Preparation of carbomer solution: take a formula amount of carbomer, use purified water to swell the carbomer, and prepare a carbomer solution;

[0020] Preparation of polyvinyl alcohol solution: dissolve polyvinyl alcohol in purified water to prepare the solution;

[0021] Preparation of preservative solution: dissolve the preservative in the moisturizer to prepare the solution;

[0022] Preparation of gel solution: polyvinyl alcohol solution, moisturizer, preservative solution and pH adjuster are sequentially added to carbomer solution to prepare gel solution;

[0023] Preparation of cold compress eye patch: Fill the gel solution into an aluminum foil bag containing non-woven fabric and seal it.

[0024] According to one embodiment of the present invention, the following steps are included:

[0025] Preparation of carbomer solution: take a formula amount of carbomer, use an appropriate amount of purified water to swell the carbomer, and prepare a carbomer solution;

[0026] Preparation of polyvinyl alcohol solution: dissolve polyvinyl alcohol in appropriate amount of purified water;

[0027] Preparation of preservative solution: Take appropriate amount of propylene glycol to dissolve the preservative to prepare;

[0028] Preparation of gel solution: polyvinyl alcohol solution, remaining purified water, 1,3-butylene glycol, glycerol, preservative solution and pH adjuster are sequentially added to carbomer solution to prepare gel solution;

[0029] Preparation of cold compress eye patch: fill the gel solution into an aluminum foil bag containing non-woven fabric and seal it;

[0030] The mass percentage of each component of the gel solution is: carbomer 0.02%-0.5%, triethanolamine 0.01%-0.10%, polyvinyl alcohol 0.2%-0.8%, ethyl p-hydroxybenzoate 0.01%-0.20%, propylene glycol 2-10%, 1,3-butylene glycol 2-10%, glycerol 2-10%, and purified water, which is supplemented to 100%.

[0031] According to a preferred embodiment of the present invention, the following steps are included:

[0032] Carbomer solution preparation:

[0033] Take 17.22 parts of purified water into a stainless steel container, slowly add 0.04 parts of Carbomer 380, stir for 15 minutes, let stand for 1 hour, and then stir for another 15 minutes. Soak for more than 15 hours to allow Carbomer 380 to swell completely, and then stir for another 15 minutes.

[0034] Polyvinyl alcohol solution preparation:

[0035] Take 4.3 parts of purified water, use an electronic constant speed stirrer, set to 500 rpm for stirring, slowly add 0.75 parts of polyvinyl alcohol, stir for 5 minutes, and heat in a water bath until the polyvinyl alcohol is completely dissolved.

[0036] Preparation of ethyl paraben solution:

[0037] Take a stainless steel container, add 0.1 parts of ethyl p-hydroxybenzoate and 4 parts of propylene glycol, and stir for 15 minutes to completely dissolve the ethyl p-hydroxybenzoate.

[0038] Add polyvinyl alcohol solution to the carbomer solution, add the remaining amount of purified water, and stir for 15 minutes.

[0039] Add 4 parts of 1,3-butanediol and 5 parts of glycerol in sequence and stir for 15 minutes.

[0040] Add the dissolved ethyl p-hydroxybenzoate and stir for 15 minutes.

[0041] Add 0.02 parts of triethanolamine, stir for 15 minutes, and let stand for more than 30 minutes after stirring.

[0042] The gel solution was filled into polyethylene aluminum foil bags containing non-woven fabrics, 6.5 g per bag, and sealed.

[0043] According to a third aspect of the present invention, there is provided a use of a medical cold compress eye patch in preparing a medical device for relieving dry eye syndrome.

[0044] It should be noted that the "active pharmaceutical ingredients" of the present invention refer to substances that have pharmacological activity or other direct effects or can affect the function or structure of the body in the diagnosis, treatment, symptom relief, treatment or prevention of diseases. For example, Chinese medicine, chemical drugs, biological products, disinfection and antibacterial ingredients, natural plants and their extracts, etc., which have pharmacological, immunological, and metabolic effects.

[0045] The eye patch provided by the present invention creates a relatively humid closed environment for the eye skin without any medicinal ingredients, thereby relieving discomfort symptoms such as eye fatigue, dryness, foreign body sensation, etc., thereby achieving the effect of relieving dry eye syndrome.

[0046] The beneficial effects of the present invention are mainly reflected in:

[0047] 1. The medical cold compress eye patch of the present invention has simple ingredients, is safe, effective and has excellent adhesion.

[0048] 2. The medical cold compress eye patch of the present invention can relieve dry eye syndrome without any active pharmaceutical ingredient. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 : Gel liquid test experiment, wetting effect diagram of Examples 1-2 and Comparative Examples 1-3.

[0050] Figure 2 :Eye patch product effect experiment, body temperature and time-temperature graph of subjects in different time periods.

[0051] Figure 3 : Eye patch product effect experiment, temperature and time diagram of subjects' body temperature at different test sites.

[0052] Figure 4 :Eye patch product effect experiment, temperature and time temperature graph of subjects of different genders.

[0053] Figure 5 :Eye patch product effect experiment, temperature and time temperature graph of subjects of different ages.

[0054] Figure 6 : Eye patch product effect experiment, trend chart of application time and temperature difference. DETAILED DESCRIPTION

[0055] The embodiments of the present invention are described in detail below. The embodiments are further descriptions of the present invention, but the protection scope of the present invention is not limited thereto.

[0056] Gel

[0057] Example 1

[0058] The gel solution for medical cold compress eye patch was prepared according to the formula and process listed in Table 1.

[0059] Table 1

[0060]

[0061]

[0062] 1) Preparation of Carbomer solution:

[0063] Take the formulated amount of purified water, add the formulated amount of Carbomer 380, stir and allow to swell.

[0064] 2) Preparation of polyvinyl alcohol solution:

[0065] Take purified water, add polyvinyl alcohol, stir evenly, and heat in a water bath until the polyvinyl alcohol is completely dissolved.

[0066] 3) Preparation of ethyl p-hydroxybenzoate solution:

[0067] Take a stainless steel container, add the prepared amount of ethyl p-hydroxybenzoate and propylene glycol, and stir to completely dissolve the ethyl p-hydroxybenzoate.

[0068] 4) Gel solution preparation:

[0069] Add polyvinyl alcohol solution to the carbomer solution, add the remaining amount of purified water, and stir evenly;

[0070] Add the prepared amount of 1,3-butanediol and glycerol in sequence and stir evenly;

[0071] Add dissolved ethyl p-hydroxybenzoate and stir evenly;

[0072] Add triethanolamine and stir evenly to obtain a gel solution.

[0073] Example 2

[0074] The gel solution was prepared according to the formulation listed in Table 2 and the preparation process described in Example 1.

[0075] Table 2

[0076] name Mass percentage Carbomer 380 0.05 Polyvinyl alcohol 0.6 Triethanolamine 0.05 Ethyl paraben 0.1 Propylene glycol 2 1,3-Butanediol 8 glycerin 5 Purified water 84.20 total 100

[0077] Example 3

[0078] The gel solution was prepared according to the formulation listed in Table 3 and the preparation process described in Example 1.

[0079] Table 3

[0080] name Mass percentage Carbomer 380 0.04 Polyvinyl alcohol 0.50 Triethanolamine 0.02 Ethyl paraben 0.20 Propylene glycol 3 1,3-Butanediol 5 glycerin 8 Purified water 83.24 total 100

[0081] Example 4

[0082] The gel solution was prepared according to the formulation listed in Table 4 and the preparation process described in Example 1.

[0083] Table 4

[0084] name Mass percentage Carbomer 380 0.02 Polyvinyl alcohol 0.8 Triethanolamine 0.01 Ethyl paraben 0.1 Propylene glycol 5 1,3-Butanediol 5 glycerin 3 Purified water 86.07 total 100

[0085] Example 5

[0086] The gel solution was prepared according to the formulation listed in Table 5 and the preparation process described in Example 1.

[0087] Table 5

[0088] name Mass percentage Carbomer 380 0.05 Polyvinyl alcohol 1 Triethanolamine 0.02 Ethyl paraben 0.1 Propylene glycol 3 1,3-Butanediol 5 glycerin 5 Purified water 85.83 total 100

[0089] Comparative Example 1

[0090] The gel solution was prepared according to the formulation listed in Table 6 and the preparation process described in Example 1.

[0091] Table 6

[0092] name Mass percentage Carbomer 380 0.06 Polyvinyl alcohol 0.17 Triethanolamine 0.05 Ethyl paraben 0.01 Propylene glycol 5 1,3-Butanediol 4 glycerin 2 Purified water 88.71 total 100

[0093] Comparative Example 2

[0094] The gel solution was prepared according to the formulation listed in Table 7 and the preparation process described in Example 1.

[0095] Table 7

[0096]

[0097]

[0098] Comparative Example 3

[0099] The gel solution was prepared according to the formulation listed in Table 8 and the preparation process described in Example 1.

[0100] Table 8

[0101] name Mass percentage Carbomer 380 0.01 Polyvinyl alcohol 0.83 Triethanolamine 0.05 Ethyl paraben 0.06 Propylene glycol 2 1,3-Butanediol 5 glycerin 6 Purified water 86.05 total 100

[0102] Comparative Example 4

[0103] The gel solution was prepared according to the formulation listed in Table 9 and the preparation process described in Example 1.

[0104] Table 9

[0105]

[0106]

[0107] Gel liquid infiltration and bonding effect test

[0108] The Examples 1-5 and Comparative Examples 1-4 prepared according to the above prescription and process were subjected to the wetting and fitting test. The test method was to spread the non-woven fabric for eye mask on a plate at a ratio of 3.3g gel solution / half sheet of non-woven fabric for eye mask, drop the gel solution to the center of the non-woven fabric for eye mask, and observe its natural wetting effect. After the drop addition was completed, the wetting effect of each eye mask was as shown in the attached figure. Figure 1 shown.

[0109] It can be seen from the test results that the gel solution of the eye patch of the present invention can fully wet the carrier, and the eye mask obtained by soaking is moist, plump and uniform. When the amount of carbomer is small and the amount of polyvinyl alcohol is large, the eye mask is dry as shown in Comparative Example 3; when the amount of carbomer is large and the amount of polyvinyl alcohol is small, the gel solution is unevenly distributed as shown in Comparative Examples 1 and 2; the best effect is Example 1-2, and the eye mask is very moist, plump and uniform.

[0110] Medical cold compress eye patch containing gel solution

[0111] White bamboo fiber non-woven fabric was used as a carrier, and the gel solution prepared above was filled into a polyethylene aluminum foil bag containing the carrier, 6.5 g per bag, and the bag was sealed to prepare the corresponding eye patch product.

[0112] The eye patch products of Examples 1, 2, 3, and 4 are all good in appearance, uniformity, moisturizing effect, and usage experience; the eye patch of Example 5 has a poor usage experience, and the product effect test is no longer performed; and the eye patch products of Comparative Examples 1, 2, and 4 have insufficient viscosity and poor adherence due to excessive carbomer content or too little polyvinyl alcohol, and the cooling effect and dryness relief effect are poor. The product of Comparative Example 3 is not moisturizing enough and the moisturizing time is too short.

[0113] From the above examples and comparative examples, it can be concluded that the optimal range of the process of the prescription is 0.02% to 0.5% carbomer, 0.01% to 0.10% triethanolamine, 0.2% to 0.8% polyvinyl alcohol, 0.01% to 0.20% ethyl paraben, 2% to 10% propylene glycol, 2% to 10% 1,3-butylene glycol, 2% to 10% glycerol, and 68.40% to 93.76% purified water. Too much or too little carbomer and polyvinyl alcohol will affect the performance and effect of this product.

[0114] 1. Effect test of eye patch products containing gel solution

[0115] According to the relevant report in the document "Chun Yu Xinghua, A Brief Discussion on Physical Cooling of a Class I Medical Device - Hydrogel Patch", this experiment can verify the cooling effect by monitoring the skin temperature around the eyes at different time periods during the use of the product by the subjects. In order to prove that this product has a certain cooling effect on the skin around the eyes, thereby achieving an auxiliary treatment effect for dry eyes, the cooling effectiveness of the product in Example 1 is verified according to the following steps. This plan randomly selects 30 people and records their use of the medical cold compress eye patch.

[0116] 1. Verification scheme

[0117] 1.1 Experimental design

[0118] This study was conducted in healthy adult subjects with a double cycle and single dose. A total of 30 people aged 18-55 were selected. The subjects who met the verification population requirements applied the medical cold compress eye patch to the eye area according to the instructions on the verification day at 8:00-9:30 and 15:00-16:30. The temperature of the skin around the eyes was recorded once before using the product, and the temperature of the skin around the eyes was recorded once 10 minutes, 15 minutes, and 20 minutes after using the product.

[0119] After the test, the product was removed and the changes in the ocular surface temperature of the test population were counted. The test subjects included male and female subjects with an appropriate gender ratio and age coverage of people of all age groups. The test product was given once per cycle.

[0120] 2. Verification process

[0121] 2.1 Evaluation method: physical cooling test

[0122] 2.1.1 The research method of cold compress cooling test was confirmed. The test method referred to the physical cooling test method in "Chun Yu Xinghua, A Brief Discussion on Physical Cooling of Class I Medical Devices - Hydrogel Patches, Qilu Pharmaceutical Affairs 2007 Vol. 26, No. 3".

[0123] 2.1.2 Test methods

[0124] Validation population screening: 30 people in different age groups aged 18-55 were selected

[0125] Patients who meet the verification population requirements will apply the medical cold compress eye patch to the eye area according to the instructions on the verification day at 8:00-9:30 and 15:00-16:30. Before using the product, record the temperature of the skin around the eyes and score the eye symptoms. After using the product for 10 minutes, 15 minutes, and 20 minutes, record the temperature of the skin around the eyes.

[0126] After the test, remove the product and record the changes in ocular surface temperature and improvement in eye symptoms of the subjects, and fill in the table below.

[0127] Table 10

[0128]

[0129] Table 11. Scoring criteria for eye symptoms

[0130]

[0131]

[0132] 3. Verification summary:

[0133] Statistical analysis of the data from 30 subjects during use showed that after using the medical cold compress eye patch, the temperature around the eyes of the subjects decreased. The degree of decrease was related to the age and gender of the subjects. The analysis process is as follows:

[0134] 3.1 The body's temperature varies at different times. Using medical cold compress eye patches can lower the temperature of the skin around the eyes.

[0135] Time (min) 0 10 15 20 Left eye-average temperature in the morning (℃) 31.23 28.56 27.8 26.72 Left eye-average temperature in the afternoon (℃) 31.76 28.68 27.63 26.82

[0136] 3.2 There was little difference in the test areas of the subjects. Using medical cold compress eye patches can reduce the temperature of the skin around the eyes.

[0137] Time (min) 0 10 15 20 Left eye-average temperature in the morning (℃) 31.23 28.56 27.8 26.72 Right eye-average temperature in the morning (℃) 31.2 28.59 27.81 26.83

[0138] 3.3 Men have higher body temperature than women. The difference in the degree of decrease in skin temperature around the eyes after using medical cold compress eye patches for 20 minutes is small.

[0139] Time (min) 0 10 15 20 Average temperature around the eyes of women (℃) 30.92 27.98 27.19 26.46 Average temperature around the eyes of men (℃) 31.51 29.17 28.42 27.09

[0140] 3.4 Young people have higher body temperature. When they use medical cold compress eye patches for 20 minutes, the temperature of the skin around their eyes drops less.

[0141] Time (min) 0.00 10.00 15.00 20.00 Average eye temperature of subjects with an average age of 45 (℃) 31.06 28.38 27.41 26.34 Average eye temperature of subjects with an average age of 29 (℃) 31.37 28.77 28.20 27.22

[0142] 3.5 Young people have higher body temperature. When young people use medical cold compress eye patches for 20 minutes, the temperature of the skin around their eyes drops less.

[0143] Time (min) 0 10 15 20 Changes in local temperature around the eye (℃) 0 -2.64 -3.41 -4.44

[0144] 3.6 Scoring of eye symptoms before and after the use of medical cold compress eye patch.

[0145] Pre-use rating form

[0146] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 5 12 13 38 1.27

[0147] Post-use rating form

[0148] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 13 13 4 21 0.70

[0149] The test results show that the temperature change curves of the left and right eyes are almost the same, and the temperature change curves of subjects of different genders and ages also conform to the general rules. The average scores in the symptom score table before and after use have decreased significantly, indicating that the experimental design method is reliable and can obtain more realistic results. Within 20 minutes of use, the medical cold compress eye patch can reduce the temperature of the skin around the eyes by about 4°C, which can have the effect of cold compress; from the eye symptom score table, it can be seen that the medical cold compress eye patch can significantly relieve the symptoms of dry eyes and eye soreness, thereby providing auxiliary treatment for dry eyes.

[0150] According to the above effect test scheme of the eye patch containing gel solution, the products of Examples 2, 3 and 4 were subjected to physical cooling verification, and the cooling effects were consistent.

[0151] Scoring of eye symptoms before and after using the medical cold compress eye patch Example 2.

[0152] Pre-use rating form

[0153] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 6 10 14 38 1.27

[0154] Post-use rating form

[0155] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 12 14 4 22 0.73

[0156] Scoring of eye symptoms before and after using the medical cold compress eye patch Example 3.

[0157] Pre-use rating form

[0158] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 6 9 15 39 1.3

[0159] Post-use rating form

[0160] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 9 16 5 26 0.87

[0161] Scoring of eye symptoms before and after using the medical cold compress eye patch Example 4.

[0162] Pre-use rating form

[0163] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 6 10 14 38 1.3

[0164] Post-use rating form

[0165] symptom 0 points 1 point (light) 2 points (medium) Total score Average score Dry eyes, sore eyes 11 14 5 24 0.80

[0166] The conclusion is consistent with that in Example 1, which shows that the medical cold compress eye patch provided by the present invention, which does not contain active pharmaceutical ingredients, not only has a good moisturizing and cooling effect, but also can assist in relieving dry eye syndrome.

[0167] II. Irritation and skin sensitization test of eye patch products

[0168] 1. Test methods

[0169] According to GB / T 16886.10-2017 Biological evaluation of medical devices Part 10: Irritation and skin sensitization test, an eye irritation test was used. 0.1 ml of the test sample extract of Example 1 was dripped into the lower conjunctival sac of one eye of the animal, and the contralateral eye was treated with the control solution in the same way. Both eyes of each animal were examined at about 1 (± 0.1) h; 24 (± 2) h; 48 (± 2) h and 72 (± 2) h after instillation, and the scores were recorded according to the eye damage scoring system, as shown in Table 12.

[0170] Table 12 Eye damage scoring system

[0171]

[0172]

[0173] NOTE: Other adverse reactions occurring in the area of ​​eye irritation should be recorded and reported.

[0174] 2. Select healthy, unused, newly grown white purebred New Zealand rabbits and raise them individually in cages. Label them with numbers, test codes, and test start dates.

[0175] 3. Extract Preparation

[0176] Take samples under sterile conditions, take a pair of samples, and use the standard surface area of ​​the contact part of the sample prepared in Example 1, 48cm 2 / pieces, and shake and extract in a sealed inert container according to the extraction ratio (sample: extraction medium) in the following table. The extraction medium is sesame oil and 0.9% sodium chloride injection.

[0177]

[0178] The state of the extract did not change before and after leaching. After leaching, it was stored at room temperature and used for testing within 24 hours. The pH value of the extract was not adjusted, and it was not filtered, centrifuged, diluted, etc. The control solution was prepared under the same conditions without adding the test sample.

[0179] 4. Check both eyes of each animal for abnormalities within 24 hours before the experiment, eliminate animals with abnormalities, and use 2% sodium fluorescein to check for corneal damage during eye examination.

[0180] 5. Experimental steps

[0181] 0.1 ml of the test sample extract was dripped into one eye of the animal, and the eye was closed for about 1 second after the drip. The contralateral eye of each animal was dripped with control solution as a control.

[0182] In the initial test, one animal is used to evaluate the test material. If one animal shows a clear positive reaction (see Table 12), there is no need to use the animal for testing again. If no clear reaction is shown, at least two more animals should be used for testing.

[0183] After using at least 3 animals, if the test reaction is still suspicious or unclear, retesting should be considered.

[0184] 6. Observation of results

[0185] The animals instilled with the test material should have both eyes of each animal examined approximately 1 (± 0.1) h; 24 (± 2) h; 48 (± 2) h and 72 (± 2) h after instillation. The observed reactions should be scored and recorded according to the eye injury grading system specified in Table 12. If there is persistent damage, the observation time should be extended to determine the progression and reversibility of the damage, but the extension period shall not exceed 21 days.

[0186] 7. Results Evaluation

[0187] If more than one animal's eyes show a positive reaction at any stage of observation (marked with * in Table 12), the material is considered to be an eye irritant and no further testing is required.

[0188] If only one of the three animal test eyes shows a moderate reaction or a suspected reaction, another animal should be taken for retest. If more than half of the animal test eyes show a positive reaction at any observation stage during the retest (marked with * in Table 12), the test material is considered to be an eye irritant.

[0189] Severe reactions in only one animal were sufficient to confirm that the material was an eye irritant.

[0190] 8. This experiment was carried out strictly in accordance with the above plan, and no deviation occurred that affected the validity of the experimental data.

[0191] 9. Test results

[0192] The observation results are listed in Tables 13 and 14. The clinical manifestations of all animals were normal.

[0193] 10. Conclusion

[0194] Under the conditions of this experiment, compared with the control group, the extract of the sample medical cold compress eye patch did not cause irritation to the rabbit eyes.

[0195] Table 13 Observation of eye irritation reaction results (extraction medium is sesame oil)

[0196]

[0197]

[0198] Table 14 Observation of eye irritation reaction results (extraction medium is 0.9% sodium chloride injection)

[0199]

Claims

1. A medical cold compress eye patch, It is characterized in that The medical cold compress eye patch comprises a carrier and a gel solution attached to the carrier, wherein the gel solution comprises carbomer, a preservative, polyvinyl alcohol, a pH value adjuster, a moisturizer and purified water, and the mass ratio of the carbomer to the polyvinyl alcohol is in the range of 0.015 to 0.2:

1.

2. The medical cold compress eye patch according to claim 1, It is characterized in that The preservative is selected from ethyl p-hydroxybenzoate; the pH adjuster is selected from triethanolamine; the moisturizer is selected from one or more of propylene glycol, 1,3-butylene glycol and glycerol; the mass percentages of each component are as follows: carbomer 0.01% to 1%, triethanolamine 0.01% to 0.50%, polyvinyl alcohol 0.1% to 1%, ethyl p-hydroxybenzoate 0.01% to 0.50%, moisturizer 6% to 30%, purified water 67.00% to 93.87%.

3. The medical cold compress eye patch according to claim 1, It is characterized in that The gel solution does not contain any active pharmaceutical ingredient.

4. The medical cold compress eye patch according to claim 1, It is characterized in that The mass percentage of the carbomer is 0.02-0.5%; the mass percentage of the polyvinyl alcohol is 0.2-0.8%.

5. The medical cold compress eye patch according to claim 1, It is characterized in that The mass ratio of the carrier to the gel solution is 1:3 to 1:

5.

6. The medical cold compress eye patch according to claim 1, It is characterized in that The carrier is bamboo fiber non-woven fabric.

7. The medical cold compress eye patch according to claim 1, It is characterized in that The carbomer is carbomer 380.

8. A method for preparing the medical cold compress eye patch according to any one of claims 1 to 7, It is characterized in that The following steps are involved: Prepare the gel solution according to the formula, put the carrier into the packaging bag, take the gel solution and add it into the packaging bag to make the gel solution infiltrate the carrier; and prepare the medical cold compress eye patch.

9. The preparation method according to claim 8, It is characterized in that The following steps are involved: Preparation of carbomer solution: take a formula amount of carbomer, use purified water to swell the carbomer, and prepare a carbomer solution; Preparation of polyvinyl alcohol solution: dissolve polyvinyl alcohol in purified water to prepare the solution; Preparation of preservative solution: dissolve the preservative in the moisturizer to prepare the solution; Preparation of gel solution: polyvinyl alcohol solution, moisturizer, preservative solution and pH adjuster are sequentially added to carbomer solution to prepare gel solution; Preparation of medical cold compress eye patch: fill the gel liquid into an aluminum foil bag containing non-woven fabric and seal it.

10. Use of the medical cold compress eye patch according to any one of claims 1 to 7 in preparing a medical device for relieving dry eye syndrome.